Position in ILMN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,816,622
+$1,343,601 QoQ
Shares Held
30,964
+64.2% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 20261832 Asset Management L.P. holds $1,680,723,574 across 7 Diagnostics & Research names. ILMN ranks #5 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,969,618 | $968,126,335 | |
| 2 | DHR |
Danaher Corp /De/
|
2,334,521 | $442,625,181 | |
| 3 | ICLR |
Icon PLC
|
1,193,240 | $132,043,938 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
757,430 | $129,172,112 | |
| 5 | ILMN |
Illumina, Inc.
This page
|
30,964 | $3,816,622 | |
| 6 | LH |
Labcorp Holdings Inc.
|
9,905 | $2,642,753 | |
| 7 | WAT |
Waters Corp /De/
|
7,712 | $2,296,633 |
All Filings in ILMN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,816,622 | 30,964 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,473,021 | 18,855 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,607,177 | 16,923 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,578,463 | 16,544 | Shares | Sole | 2025-08-13 | |
| 2023-09-30 | $19,096,348 | 143,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $729 | 4 | Shares | Sole | 2023-08-14 | |
| 2021-09-30 | $415,079 | 1,052 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,365 | 16 | Shares | Sole | 2021-08-20 | |
| No filing history on record for this holder in this stock. | ||||||